Phoenix Biotech Acquisition (PBAX) Stock Price, News & Analysis

Company Overview

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.

Key Stats

• Today's Range: $4.91 to $5.95
• 50-Day Range: $5.05 to $6.33
• 52-Week Range: $4.12 to $12.80
• Volume: 6,400 shs
• Average Volume: 16,686 shs
• Market Capitalization: $36.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBAX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Phoenix Biotech Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phoenix Biotech Acquisition investors own include Sigma Lithium (SGML), Albemarle (ALB), Cost Plus (CPWM), Ford Motor (F), AstraZeneca (AZN), Alibaba Group (BABA) and ProShares Ultra Bloomberg Natural Gas (BOIL).

Company Calendar

• Today: 2/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Unclassified
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:PBAX
• CUSIP: N/A
• CIK: 1870404
• Web: www.phoenixbiotechacquisitioncorp.com
• Phone: 215-731-9450
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,250,000
• Free Float: 949,000
• Market Cap: $36.56 million
• Optionable: Not Optionable
• Beta: 0.05